Global Antimicrobial Resistance Surveillance Market Size, by Solution (Kits, System, Surveillance Software, Service), Application, End User and Regional Forecasts 2025-2035

Valued at approximately USD 6.36 billion in 2024, the Global Antimicrobial Resistance (AMR) Surveillance Market is poised to expand at a CAGR of 5.60% between 2025 and 2035, propelled by escalating global health concerns over the spread of drug-resistant pathogens. AMR surveillance has become a critical linchpin in the fight against emerging infectious diseases, enabling healthcare providers and policymakers to track resistance patterns, implement targeted interventions, and adapt treatment protocols effectively. The rising prevalence of hospital-acquired infections, combined with the steady increase in multi-drug resistant bacteria, is pushing governments, healthcare systems, and research bodies to invest heavily in robust surveillance infrastructure. This market’s growth is further reinforced by international health mandates, technological innovations in molecular diagnostics, and a concerted push toward integrating surveillance data across borders for more rapid and precise response strategies.

The momentum is being fueled by the heightened recognition that real-time, data-driven insights can substantially mitigate the impact of antimicrobial resistance. Healthcare organizations and public health bodies are accelerating adoption of sophisticated software platforms, rapid diagnostic kits, and advanced surveillance systems to pinpoint resistance trends with greater accuracy. According to WHO projections, AMR could cause millions of deaths annually by mid-century if unchecked, underlining the urgency for expansive surveillance networks. Furthermore, integration of artificial intelligence and cloud-based analytics into AMR tracking is creating unprecedented opportunities to streamline data collection, automate reporting, and strengthen cross-sectoral collaboration. However, despite its vital role, the market faces constraints in the form of limited funding in low-resource settings, uneven laboratory capacities, and the challenges of harmonizing global data standards.

From a regional perspective, North America currently commands a dominant position in the AMR surveillance market, benefiting from its well-developed healthcare infrastructure, significant R&D investment, and stringent public health regulations that mandate systematic resistance monitoring. Europe follows closely, with robust surveillance programs like EARS-Net driving collaborative data-sharing efforts across member states. Meanwhile, Asia Pacific is projected to register the fastest growth over the forecast period, spurred by the escalating burden of infectious diseases in densely populated countries such as India and China, coupled with rising governmental and private-sector investments in healthcare IT. Latin America and the Middle East & Africa are gradually strengthening their surveillance networks, although infrastructural and funding gaps remain hurdles to fully realizing market potential.

Major market players included in this report are:
• bioMérieux SA
• F. Hoffmann-La Roche Ltd.
• Thermo Fisher Scientific Inc.
• Becton, Dickinson and Company
• Abbott Laboratories
• Danaher Corporation
• Siemens Healthineers AG
• Bruker Corporation
• Qiagen N.V.
• Illumina, Inc.
• OPKO Health, Inc.
• Hologic, Inc.
• Cepheid (A Danaher Company)
• Luminex Corporation
• Meridian Bioscience, Inc.

Global Antimicrobial Resistance Surveillance Market Report Scope:
• Historical Data – 2023, 2024
• Base Year for Estimation – 2024
• Forecast period - 2025-2035
• Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
• Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa



The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within the countries involved in the study. The report also provides detailed information about crucial aspects, such as driving factors and challenges, which will define the future growth of the market. Additionally, it incorporates potential opportunities in micro-markets for stakeholders to invest, along with a detailed analysis of the competitive landscape and product offerings of key players.

The detailed segments and sub-segments of the market are explained below:

By Solution:
• Kits
• System
• Surveillance Software
• Service

By Application:
• Clinical Diagnostics
• Public Health Surveillance

By End User:
• Hospitals
• Clinics
• Academic
• Research Institutes

By Region:

North America
• U.S.
• Canada

Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE

Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC

Latin America
• Brazil
• Mexico

Middle East & Africa
• UAE
• Saudi Arabia
• South Africa
• Rest of Middle East & Africa

Key Takeaways:
• Market Estimates & Forecast for 10 years from 2025 to 2035.
• Annualized revenues and regional level analysis for each market segment.
• Detailed analysis of geographical landscape with Country level analysis of major regions.
• Competitive landscape with information on major players in the market.
• Analysis of key business strategies and recommendations on future market approach.
• Analysis of competitive structure of the market.
• Demand side and supply side analysis of the market.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions. Show more